🧬 In a retrospective analysis, Arnab Basu, M.D., MPH, Assistant Professor in the UAB Division of Hematology and Oncology, found that patients with muscle-invasive bladder cancer who had detectable circulating tumor DNA before radical cystectomy had shorter disease-free survival and higher recurrence rates. Learn More ➡️ https://lnkd.in/ekK6BK3N
UAB Department of Medicine’s Post
More Relevant Posts
-
Associate Professor Biochemistry University of Sadat City. Ph.D graduate-McGill University with expertise in the field of Molecular Biochemistry. Past Senior Research Associate in Pharmacology, Université de Montréal
I am thrilled to share our recent publication entitled "Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay" in Medical Oncology Journal, Q2 Thanks for the whole team https://lnkd.in/dYRBB_zF
To view or add a comment, sign in
-
The ATR inhibition by Elimusertib enhances the radiosensitivity of MDA-MB-231 triple negative breast cancer in vitro https://bit.ly/4bkBH8i
To view or add a comment, sign in
-
The first report from the Cancer Programme of the 100,000 Genomes Project, published in Nature Medicine, presents whole-genome sequencing profiles of 13,880 solid tumors spanning 33 cancer types, combined with real-world clinical data, providing insights for precision oncology. Read the paper: https://lnkd.in/eUj3pKgA
To view or add a comment, sign in
-
For the folk’s interested in targeting MTAP homozygous deletions - this is an excellent dataset to get a reliable patient count / provided the algorithm to call homozygous deletions is fully reliable
The first report from the Cancer Programme of the 100,000 Genomes Project, published in Nature Medicine, presents whole-genome sequencing profiles of 13,880 solid tumors spanning 33 cancer types, combined with real-world clinical data, providing insights for precision oncology. Read the paper: https://lnkd.in/eUj3pKgA
To view or add a comment, sign in
-
Interesting paper with further insights for precision oncology
The first report from the Cancer Programme of the 100,000 Genomes Project, published in Nature Medicine, presents whole-genome sequencing profiles of 13,880 solid tumors spanning 33 cancer types, combined with real-world clinical data, providing insights for precision oncology. Read the paper: https://lnkd.in/eUj3pKgA
To view or add a comment, sign in
-
📚💡❗ARV-471 Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer
To view or add a comment, sign in
-
A pooled analysis exploring tumor intrinsic subtypes in 3 trials on HER2+ EBC - Elisa Agostinetto JAMA Oncology OncoAlert #BreastCancer #Research #Cancer #HER2E #JAMAOncology #OncoDaily #Oncology #PCR #TumorSubtypes
Elisa Agostinetto: A pooled analysis exploring tumor intrinsic subtypes in 3 trials on HER2+ EBC - OncoDaily
oncodaily.com
To view or add a comment, sign in
-
Molecular docking study of ethyl acetate fraction of Selaginella doederleinii Hieron extract as anti-Warburg effect in breast cancer. https://ow.ly/xRrY50Qx3en
To view or add a comment, sign in
-
Innovative Tech Strategist | Tailoring and implementing cutting-edge solutions to drive your business forward
- The Cancer Programme was part of the 100,000 Genomes Project focusing on whole-genome sequencing (WGS) for cancer patients within the UK. - Genomics England and NHS England analyzed WGS data from 13,880 solid tumors covering 33 cancer types. - The analysis integrated genomic data with real-world treatment. - Incidence of somatic mutations varied across cancer types; for instance, glioblastoma multiforme exhibited 94% small variants and 58% copy number aberrations. - Sarcoma showed the highest occurrence of actionable structural variants (13%). - Homologous recombination deficiency was identified in 40% of high-grade serous ovarian cancer cases, with 30% linked to pathogenic germline variants. - Linking WGS and longitudinal clinical data allowed survival analysis, identifying cancer genes impacting prognosis and enhancing understanding of cancer genomics' effect on patient outcomes.
The first report from the Cancer Programme of the 100,000 Genomes Project, published in Nature Medicine, presents whole-genome sequencing profiles of 13,880 solid tumors spanning 33 cancer types, combined with real-world clinical data, providing insights for precision oncology. Read the paper: https://lnkd.in/eUj3pKgA
To view or add a comment, sign in
-
Oncólogo Radioterápico y Médico Nuclear | Maestría Neuro-Oncología | MBA Dirección de Empresas | Savia Care | Encargado División Radioncología INCART | Encargado Unidad de Radioterapia HOMS
Toxicity of external beam accelerated partial- breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study. https://lnkd.in/eC_ngPwy
To view or add a comment, sign in
1,022 followers